Chiara Cremolini - Concepedia

Author

Chiara Cremolini

Azienda Ospedaliera Universitaria Pisana ORCID

Also Known As

C Cremolini, C. Cremolini, C., Cremolini, CHIARA CREMOLINI, Chiara Cremolini, Cremolini, Chiara, Einat Shacham-Shmueli, Federica Marmorino, Richard M. Goldberg, Siena, S.

968

Publications

20.1K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera Universitaria Pisana University of Pisa Istituto Oncologico Veneto Fondazione IRCCS Istituto Nazionale dei Tumori Istituti di Ricovero e Cura a Carattere Scientifico

About

Chiara Cremolini is an author at Azienda Ospedaliera Universitaria Pisana specializing in medicine, oncology, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	89	7.3K
2	Health Sciences	11	12	546
3	Public Health	2	2	61
4	Engineering	1	1	24
5	Biochemistry	1	1	13

Chiara Cremolini

200

Publications

16.5K

Citations

H-Index

Page 1

	Year	Citations
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Nature Medicine MedicinePathologyColorectal CancerColorectal Cancer PatientsEgfr Blockade	2015	1.1K
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, The Lancet Oncology Phase 3Gastrointestinal OncologyMedicinePathologyColorectal Cancer	2015	1.1K
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer Fotios Loupakis, Chiara Cremolini, Gianluca Masi, New England Journal of Medicine	2014	1.1K
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini, British Journal of Cancer	2009	557
Quantitative evidence for early metastatic seeding in colorectal cancer Zheng Hu, Jie Ding, Zhicheng Ma, Nature Genetics Quantitative EvidenceMedicineColorectal CancerPathologyOncology	2019	508
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer Fotios Loupakis, Dongyun Yang, Linda Yau, JNCI Journal of the National Cancer Institute	2015	489
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer Fotios Loupakis, Luca Emanuele Pollina, I. Stasi, Journal of Clinical Oncology	2009	402
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila, JAMA Oncology	2018	397
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer Gerald W. Prager, Marwan Fakih, Fortunato Ciardiello, New England Journal of Medicine	2023	375
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock, JNCI Journal of the National Cancer Institute	2017	322

Page 1